Early independence: clinician scientist fellowship 2026-2027 (MRC)

Early independence: clinician scientist fellowship 2026-2027 (MRC)

The Medical Research Council (MRC), part of UK Research and Innovation (UKRI), funds this fellowship for registered healthcare professionals seeking a step-change toward independence as clinical researchers. Its purpose is to give an established clinician-scientist candidate protected time, salary and research costs to define a distinct research niche, lead a programme of work and begin building a team. It is aimed at applicants with a higher research degree and a record of development and productivity, rather than at people seeking their first research training or a conventional project grant.

The UKRI funding-finder page currently labels the September 2026 round closed and gives that round’s dates in its main application instructions. Its published timeline also announces a following application window from 21 October 2026 to 13 January 2027. The next window has been announced but has not yet opened. MRC lists another window from 14 January to 7 April 2027 and a further window from June to September 2027. Use 13 January 2027 as the closing date for the upcoming window, and check the live opportunity and Funding Service instructions when it opens: the detailed application section on the funding-finder page still contains the September round’s 2 September 2026 deadline.

Key facts

Purpose and research fit

This is a career-development award, not simply a salary supplement attached to an existing group’s research. MRC expects the fellow to own their research plans, define a niche that does not significantly overlap with current group leaders or proposed sponsors, and take the first clear step toward independence. Applications should explain why a fellowship is the right mechanism for the applicant’s longer-term career, how the proposed work advances human health, and how it will create a credible transition to leading research.

The research must fall within MRC’s remit to improve human health. The official scope spans basic work relevant to disease mechanisms through translational and developmental clinical research. Named areas include infections and immunity, molecular and cellular medicine, population and systems medicine, neurosciences and mental health, translation, global health, methodology and public health. Global health proposals should fit MRC’s core remit, which runs from biomedical discovery to early translational research. Longitudinal population studies are normally not suitable for this fellowship; the published guidance describes only a limited exception for core support to existing studies with prior MRC support.

A convincing case connects the candidate’s clinical experience to a research question that they can lead. It should make clear what is distinct about the proposed programme, why the applicant is ready for this transition, what expertise or facilities are needed, and how the plan can be delivered within the fellowship. Clinical relevance alone is not enough: the research must sit within MRC remit and the applicant must show both a credible scientific plan and a path to continued clinical activity.

Funding and award structure

The fellowship supports up to five years, and MRC expects applicants to make use of the full period where appropriate. Shorter proposals should be discussed with the programme manager before applying. The award covers the fellow’s salary and contributes to justified project costs. There is no stated maximum amount, but each requested cost must be appropriate to the work and demonstrate value for money. The funder pays 80% of full economic cost (FEC) and 100% of permitted exceptions; the host must account for its standard share of FEC.

Eligible costs can include a small number of research or technical staff, consumables, equipment, travel, training, data preservation and sharing, dissemination, estates and indirect costs. Public partnership activities and relevant NHS research costs may also be included. Visa fees and international health surcharge costs for the fellow and dependent family members are listed as supportable costs for eligible relocating awardees. The fellowship can support up to 12 months at a second UK organisation, overseas organisation or in industry, where that experience serves the programme. Contact MRC in advance if a longer overseas period is planned.

Staffing must match an early independence award. MRC says that requests should support the initial establishment of a group and development of those staff. Numerous enabling roles or senior staff would make the application look like a research grant and are outside the fellowship’s expectations. Host organisations are expected to provide basic space and equipment. The award will not cover PhD studentships, publication costs, bridge funding between grants, sponsor or mentor costs, or a large research team. Build a budget around what is necessary to deliver the fellow’s programme, with a clear rationale for each item.

Joint funding may be available with collaborating charities and royal colleges. The opportunity lists Addiction Healthcare Goals, DEBRA, Diabetes UK, Kidney Research UK, Macular Society, Medical Research Foundation, Motor Neurone Disease Association and Parkinson’s UK. Joint awards follow standard UKRI and MRC terms unless a co-funder specifies additional conditions. An applicant considering a joint route should check the relevant partner’s fit and requirements in the official opportunity information.

Eligibility and restrictions

Applicants must be registered healthcare professionals. The published examples include nurses, midwives, allied health professionals, healthcare scientists, pharmacists, clinical psychologists, doctors, dentists, general practitioners and veterinarians. Applicants need a completed PhD or equivalent before the fellowship award can start, evidence of skills and career development across past appointments, and a record of productivity. If a PhD is still in progress, MRC advises contacting its fellowship team before submitting to discuss the circumstances.

Medical and dental graduates should normally hold specialty registrar or consultant status, or equivalent status in general practice. Applicants who have not completed specialty training need plans to complete it and should have consulted their deanery. Non-medical healthcare professionals must have completed their professional training. Veterinarians must be registered and be members of the Royal College of Veterinary Surgeons. The proposed project still needs to be relevant to human health.

Applicants may be of any nationality and need not already live in the UK, but the host must be an eligible UK-based research organisation. Applicants must be registered with a UK regulatory body, such as the General Medical Council or Health and Care Professions Council, or have plans to obtain the required registration by the proposed award start. Applicants must intend to remain clinically active. MRC describes part-time awards as possible for personal circumstances and, for GPs, nurses, midwives, allied health and other non-medical healthcare professionals, potentially to continue clinical responsibilities. A medically qualified applicant cannot use part-time status to continue higher specialist training during the fellowship.

There are important application and employment restrictions. Only one fellowship application of the same type may be under UKRI consideration at a time. Ineligibility also applies in several circumstances, including a recent MRC fellowship application within the previous year or two earlier attempts, an assessed overlapping UKRI fellowship or project, an assessed UKRI project led by the applicant, a comparable early-independence or new-investigator award, or grants as project lead that already support and involve leading research staff. Applicants must be employed by an eligible UK organisation for the fellowship. A salaried position cannot normally be held at the same time; MRC describes exceptional cases where an applicant can demonstrate a clear career-route change, subject to giving up or changing the existing role to a proleptic appointment if awarded.

Preparing and submitting an application

Applications use the UKRI Funding Service, not Je-S. The published instructions say the fellow completes the application, while the host research office helps with costing and institutional submission. Only the lead research organisation can submit to UKRI. If the intended host is an NHS organisation, check early that it is available in the Funding Service because setup may be needed. Confirm the host’s eligibility, costing arrangements and internal review timetable with its research office well ahead of the deadline.

The next announced window opens on 21 October 2026. When it opens, follow the live funding-finder page’s Start application link, confirm that you are the fellow, sign in or create a Funding Service account, and select the organisation that will host the fellowship. Answer the questions in the service’s text boxes; UKRI says applicants may save responses and return later or draft offline and paste them in. Follow the service’s upload instructions for any requested documents. Before submission, review the read-only version, send it to the research office for costing and checks, and leave enough time for the lead organisation to submit. The current detailed instructions still display the closed September round’s deadline, so check the January window’s live guidance and deadline wording when the application opens. The published timeline gives 13 January 2027 as the close for that window.

The funding-finder page outlines the application’s substantive case: a plain-English summary, a strong vision, a feasible approach and project plan, career development, evidence of capability, sponsor and host support, and justified resources. It also asks for relevant information on clinical activity, reproducibility and statistical design, data management, ethics, facilities and any partners. At least one sponsor must be a senior member of the host department with academic responsibility for the applicant; the sponsor supports but does not supervise the fellowship. Use the question headings and assessment guidance shown in the live Funding Service when the new window opens, because UKRI may revise its form or instructions between rounds.

Plan the written case around the official questions and assessment criteria. The summary should plainly describe the context, challenge, objectives and possible benefits. The vision should explain the importance, timeliness and potential contribution to research or health, including beneficiaries and plans for engagement and dissemination. The approach needs a transparent method, delivery plan, risks and mitigations, milestones, access to facilities, and relevant collaborations. Address reproducibility and statistical design where relevant, and give the requested PhD information and career history. The required sponsor is a senior member of the host department who supports the application but is not a supervisor; the sponsor should be able to vouch for the work, candidate and development environment. Additional sponsors may be included when needed to cover the work’s areas of expertise.

Keep supporting material focused. References count within the relevant answer’s word limit and should be pertinent and easy to identify. Hyperlinks should point directly to reference information rather than extend the case with material assessors are not expected to read. Visual material is permitted only where it communicates important information more clearly than text. Each image needs a descriptive caption outside the image, must follow the Funding Service file rules, and cannot contain paragraphs or tables; excessive images are prohibited. Project partners should have an integral role and provide a statement of support. An individual on the core team or employed by the host cannot also be a project partner, and an organisation employing a core team member is not eligible to be listed as a partner.

Published timetable and practical planning

The main funding-finder notice is for the round that opened on 10 June 2026 and closed on 2 September 2026. Those dates belong to the completed September round; its decision meeting is 17 to 18 March 2027. MRC separately announces the next application window from 21 October 2026 to 13 January 2027, with shortlisting in May 2027 and a funding meeting in July 2027. Another window is listed from 14 January 2027 to 7 April 2027, followed by a further window from June to September 2027. These are distinct opportunities in the schedule. When applying, check the live funding-finder page and select the applicable window rather than reusing the completed round’s deadline or timetable.

Before the January-closing window opens, establish host readiness, confirm personal eligibility and discuss borderline questions with MRC. Shape the independence case before building the budget: identify the research question, the part of the plan that is yours, its clinical connection, and the expertise and team needed to deliver it. Ask the research office about internal review and finance dates. When the service opens, complete the live questions, check team and partner roles, send the application for institutional review and leave time for the lead organisation’s formal submission. The detailed notice states that the September round closed at 4:00pm UK time and could not be submitted afterward; do not treat that expired deadline text as the January round’s live instructions. The MRC timeline gives the January round’s closing date as 13 January 2027. Check the opened application for the applicable time and final submission rules.

The published timetable gives the completed September round a shortlisting meeting in February 2027 and a funding decision meeting on 17 to 18 March 2027. Those decision dates apply to that round, not to the January application window. For the window closing 13 January 2027, MRC lists shortlisting in May 2027 and a funding meeting in July 2027. Awards under this opportunity are expected to start no earlier than June 2027 and no later than September 2027; discuss any different start date with MRC before the March 2027 decision meeting, as directed by the current notice.

Questions applicants commonly need to resolve

Is the upcoming round open now? No. UKRI lists the next window as opening on 21 October 2026 and closing on 13 January 2027. Use the time before opening for host and eligibility checks, planning and drafting, then follow the active application page when it opens.

Is there a fixed funding cap? No maximum request is stated. This does not mean costs are unrestricted: amounts must be justified, proportionate and good value, and the FEC funding rate and excluded costs apply.

Can applicants from outside the UK apply? Yes, provided an eligible UK research organisation hosts the award and the required UK professional registration is in place or planned by the award start.

Can the fellowship support clinical work? The applicant must intend to remain clinically active. Some non-medical applicants and GPs may request part-time arrangements to continue clinical responsibilities, but medical applicants cannot use a part-time award to continue higher specialist training.

Where should an applicant with an eligibility question start? Contact the MRC fellowship team before beginning the application. Confirm the host’s status and Funding Service setup with the research office as well.

Official information

The authoritative description, eligibility rules, award costs and application guidance are on the UKRI Early independence: clinician scientist fellowship page. MRC’s application timelines page lists the announced windows and their assessment schedule. The funding-finder page still shows the September round as closed and retains its old deadline in the detailed instructions; use the date and instructions displayed for the January application when that window opens.